Ovid Therapeutics Inc. (OVID) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts OVID Hot Sheet
Join SI Premium – FREE
Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q4 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $70 thousand versus the consensus estimate of $193.5 thousand.
For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ovid Therapeutics Inc (OVID) PT Raised to $5 at H.C. Wainwright
- Saudi Arabia shuts East-West Pipeline after attacks
- Goldman, BofA vie to manage Anthropic employee wealth post-IPO - report
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
